The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10125116 B1

PDF
Full Text
Expired
Date of Patent:
Nov. 13, 2018

Filed:

Dec. 16, 2014
Applicants:

Brandeis University, Waltham, MA (US);

University of Georgia Research Foundation, Inc., Athens, GA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Lizbeth K. Hedstrom, Newton, MA (US);

Gregory D. Cuny, Houston, TX (US);

Deviprasad R. Gollapalli, Waltham, MA (US);

Sivapriya Kirubakaran, Chennai, IN;

Sushil K. Maurya, Leeds, GB;

Boris Striepen, Athens, GA (US);

Suresh K. Gorla, Gurgaon, IN;

Corey R. Johnson, Waltham, MA (US);

Mandapati Kavitha, Gurgaon, IN;

Jihan Khan, Somerville, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07C 233/15 (2006.01); C07C 235/24 (2006.01); C07C 235/38 (2006.01); C07C 237/20 (2006.01); C07C 255/60 (2006.01); C07C 275/28 (2006.01); C07C 275/30 (2006.01); C07C 275/42 (2006.01); C07C 309/15 (2006.01); C07D 209/08 (2006.01); C07D 209/12 (2006.01); C07D 209/30 (2006.01); C07D 215/38 (2006.01); C07D 235/26 (2006.01); C07D 237/32 (2006.01); C07D 263/56 (2006.01); C07D 263/57 (2006.01); C07D 295/192 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 409/04 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01); C07D 471/08 (2006.01); C07D 491/052 (2006.01); C07D 249/06 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); C07C 233/15 (2013.01); C07C 235/24 (2013.01); C07C 235/38 (2013.01); C07C 237/20 (2013.01); C07C 255/60 (2013.01); C07C 275/28 (2013.01); C07C 275/30 (2013.01); C07C 275/42 (2013.01); C07C 309/15 (2013.01); C07D 209/08 (2013.01); C07D 209/12 (2013.01); C07D 209/30 (2013.01); C07D 215/38 (2013.01); C07D 235/26 (2013.01); C07D 237/32 (2013.01); C07D 249/06 (2013.01); C07D 263/56 (2013.01); C07D 263/57 (2013.01); C07D 295/192 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 409/04 (2013.01); C07D 413/04 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 471/08 (2013.01); C07D 491/052 (2013.01);
Abstract

Described herein are compounds, and pharmaceutically acceptable salts and prodrugs thereof, which are useful as inhibitors of IMPDH. In certain embodiments, a compound of the invention selectively inhibits a parasitic IMPDH versus a host IMPDH. Further, the invention provides pharmaceutical compositions comprising one or more compounds of the invention. The invention also relates to methods of treating various parasitic and bacterial infections in mammals. Moreover, the compounds may be used alone or in combination with other therapeutic or prophylactic agents, such as anti-virals, anti-inflammatory agents, antimicrobials and immunosuppressants.


Find Patent Forward Citations

Loading…